Nanocomposite Formulation for Therapy of Ocular Diseases
To improve the anti-angiogenic or anti-inflammatory effects, a dual-drug nanocomposite formulation was proposed for the therapy for ocular vascular diseases.
United States United Kingdom Micrometrics Tristar Cell Systems Corporation United Kingdom Qinglongshan Experimental Animal Center Vision Research
Source: dovepress.com